Literature DB >> 2311060

Tamoxifen for breast cancer: associated endometrial cancer.

S B Gusberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2311060     DOI： 10.1002/1097-0142(19900401)65:7<1463::aid-cncr2820650702>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Side effects of adjuvant tamoxifen.

Authors:  R E Leake
Journal:  BMJ       Date:  1991-10-26

2.  The effects of intermittent progesterone upon tamoxifen inhibition of tumor growth in the 7,12-dimethylbenzanthracene rat mammary tumor model.

Authors:  D F Gibson; D A Johnson; S M Langan-Fahey; M K Lababidi; W H Wolberg; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

3.  Tamoxifen and cancer of the endometrium.

Authors:  G O'Connell; A Arnold
Journal:  CMAJ       Date:  1993-06-15       Impact factor: 8.262

4.  The effect of tamoxifen on the endometrium.

Authors:  B Uziely; A Lewin; G Brufman; D Dorembus; S Mor-Yosef
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.

Authors:  Y P Dragan; S Fahey; K Street; J Vaughan; V C Jordan; H C Pitot
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 6.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

7.  The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ.

Authors:  D Robinson; L Holmberg; H Møller
Journal:  Br J Cancer       Date:  2008-07-29       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.